It was a privilege to represent HeartSciences, Inc. at a prestigious roundtable event, sponsored by the government of Vietnam and leading technology company FPT. This exciting event focused on the role of AI in the evolution of technology solutions and societal ecosystems—healthcare included. In a post-session breakout discussion, we addressed the industry-specific challenges and attributes of AI in healthcare, particularly in patient risk-stratification and clinician decision support, which are key areas of development for HeartSciences’ AI-ECG technology.
The roundtable brought together dignitaries from the U.S. and Vietnam, including Vietnam’s newly appointed General Secretary and President H.E. Mr. To Lam, as well as executives from industry leaders like Intel and AMD.
We are truly honored to have been invited as innovators and disruptors in the healthcare space and to witness the forward-thinking collaboration between governments and technology companies that is shaping the future of healthcare and diagnostic solutions.
Looking forward to leveraging these connections and insights to continue our mission of transforming cardiac diagnostics with AI-powered ECG technology to enhance patient risk-stratification and clinician decision support. Check out some of our moments from the event below!
HeartSciences will also have the opportunity to showcase our technology during the UN General Assembly on Wednesday the 25th as Mark Hilz (Chief Operating Officer) will be presenting the MyoVista wavECG Device as part of the Live Lab demonstration.
